Education
About Us
Working with TipRanks
Follow Us
Mark Coleman Insider Profile
11 Followers
Mark Coleman, Director at Axsome Therapeutics, holds 452.07K shares in Axsome Therapeutics (Ticker: AXSM). Most recently, Mark Coleman Bought 1,575 shares of Axsome Therapeutics on Sep 09, 2025 for an estimated value of $200.47K.
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
+98.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Mark Coleman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 21, 2019 - Mar 21, 2020
Return:+310.80%
The most profitable trade made by Mark Coleman
Mark Coleman's Trading History
List of latest transactions for each holding click on a transaction to see Mark Coleman's performance on stock
You May Also Like
Mark Coleman insider profile FAQ
What is the percentage of profitable transactions made by Mark Coleman?
The percentage of profitable transactions made by Mark Coleman is 50%.
What is the average return per transaction made by Mark Coleman?
The average return per transaction made by Mark Coleman is 98.30%.
What stocks does Mark Coleman hold?
Mark Coleman holds: AXSM stocks.
What was Mark Coleman’s latest transaction?
Mark Coleman latest transaction was an Informative Buy of $200.47K.
What was Mark Coleman's most profitable transaction?
Mark Coleman’s most profitable transaction was an Informative Buy of AXSM stock on March 21, 2019. The return on the trade was 310.80%.
What is Mark Coleman's role in Axsome Therapeutics?
Mark Coleman's role in Axsome Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.